ArticlePloS one2014

Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation.

Erika Terzuoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.